Deep Vein Thrombosis: Clinical Trials

5 trials for Deep Vein Thrombosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Terminated 5

Follow Deep Vein Thrombosis: new trials by email Literature Review of Deep Vein Thrombosis trials Research Report on Deep Vein Thrombosis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome
tinzaparin, Rivaroxaban - Deep Vein Thrombosis, Post Thrombotic Syndrome
Phase 4TerminatedSunnybrook Health Sciences Centre92021-11-152024-04-04
Calf Deep Vein Thrombosis Treatment Trial
Apixaban, Placebo - Deep Vein Thrombosis
Phase 4TerminatedMayo Clinic52019-02-192020-03-25
Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis
apixaban - Deep Venous Thrombosis, Upper Extremity Deep Venous Thrombosis
Phase 4TerminatedIntermountain Health Care, Inc.522017-02-222023-09-28
The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.
Clexane - Deep Vein Thrombosis
Phase 4TerminatedMelbourne Health352005-08-012013-05-30
Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study
Dalteparin sodium, Placebo - Thromboembolism, Deep Vein Thrombosis
Phase 4TerminatedPfizer82003-04-012008-09-29

Narrower conditions

Venous Thrombosis (5)  ·  Postthrombotic Syndrome (1)  ·  Thromboembolism (1)  ·  Thrombosis (1)  ·  Venous Thromboembolism (1)

Broader conditions

Cardiovascular Diseases (5)  ·  Embolism and Thrombosis (5)  ·  Vascular Diseases (5)  ·  Thrombosis (4)  ·  Thromboembolism (1)  ·  Venous Insufficiency (1)

Interventions

apixaban (2)  ·  Dalteparin (1)  ·  Enoxaparin (1)  ·  Rivaroxaban (1)  ·  Tinzaparin (1)

Sponsors

Intermountain Health Care, Inc. (1)  ·  Mayo Clinic (1)  ·  Melbourne Health (1)  ·  Pfizer (1)  ·  Sunnybrook Health Sciences Centre (1)

Countries

United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Spain (1)

Top investigators

Jean-Philippe Galanaud, MD (1)  ·  Paul Sparks, MBBS, PhD. FRACP (1)  ·  Robert D McBane (1)  ·  Scott Woller, MD (1)  ·  Susan R Kahn, MD (1)

Results publications

PMID 37907305